Core Insights - Apple's stock price reached an all-time high, boosting the share prices of related companies in the Hong Kong market [1] - Strong demand for the new iPhone 17 series is indicated, with sales in the first ten days surpassing those of the iPhone 16 series by 14% in both the US and China [1] Company Performance - Gawei Electronics saw a price increase of 5.36%, with a market capitalization of 293.55 billion and a year-to-date increase of 19.51% [2] - Hongteng Precision rose by 5.03%, with a market cap of 427.26 billion and a year-to-date increase of 60.27% [2] - Lens Technology increased by 5.00%, with a market cap of 1,421.48 billion and a year-to-date increase of 48.86% [2] - AAC Technologies experienced a 4.18% rise, with a market cap of 480.41 billion and a year-to-date increase of 9.77% [2] - Q Technology's stock rose by 3.28%, with a market cap of 175.81 billion and a year-to-date increase of 137.24% [2] - Sunny Optical Technology increased by 3.94%, with a market cap of 894.46 billion and a year-to-date increase of 19.59% [2] - FIH Mobile saw a 3.62% rise, with a market cap of 148.01 billion and a year-to-date increase of 105.54% [2] - BYD Electronics increased by 3.46%, with a market cap of 903.54 billion but a year-to-date decrease of 3.21% [2]

Core Viewpoint - Apple concept stocks have seen significant gains following strong early sales of the iPhone 17 series, which outperformed the iPhone 16 series by 14% in both China and the US markets [1] Group 1: Stock Performance - Hongteng Precision (06088) rose by 5.75%, trading at HKD 5.89 [1] - FIH Mobile (02038) increased by 4.33%, trading at HKD 19.04 [1] - Lens Technology (300433) saw a rise of 4.68%, trading at HKD 26.82 [1] - Gao Wei Electronics (01415) gained 4.8%, trading at HKD 33.64 [1] Group 2: Sales Performance - The iPhone 17 series has shown strong early sales, with the basic model's sales in China nearly doubling [1] - The overall sales of the iPhone 17 series are 14% higher than those of the iPhone 16 series [1] Group 3: Market Impact - Following the sales news, Apple's stock rose nearly 4%, reaching an all-time high [1] - Apple's total market capitalization increased to USD 3.89 trillion, making it the second-largest company by market value in the US [1] Group 4: Analyst Insights - China Galaxy (601881) reported that the new iPhone 17 series is globally popular, driven by the strong performance of the M5 chip [1] - The report suggests that there are investment opportunities due to the potential for Apple’s supply chain shipments to exceed expectations [1]

Core Viewpoint - Apple concept stocks have seen significant gains following strong early sales of the iPhone 17 series, which outperformed the iPhone 16 series by 14% in both China and the US markets [1] Group 1: Stock Performance - Hongteng Precision (06088) rose by 5.75%, trading at HKD 5.89 [1] - FIH Mobile (02038) increased by 4.33%, trading at HKD 19.04 [1] - Lens Technology (06613) saw a rise of 4.68%, trading at HKD 26.82 [1] - GoerTek (01415) gained 4.8%, trading at HKD 33.64 [1] Group 2: Sales Performance - The iPhone 17 series has shown strong early sales, with the basic model's sales in China nearly doubling [1] - Apple's total market capitalization reached USD 3.89 trillion, making it the second-largest company by market value in the US [1] Group 3: Market Insights - Counterpoint's report indicates that the new iPhone 17 series is well-received globally, driven by the performance of the M5 chip [1] - China Galaxy's research suggests that the Apple supply chain may present investment opportunities due to higher-than-expected shipment volumes [1]

Core Viewpoint - Apple-related stocks showed active performance, with significant gains observed in several companies following a meeting between Apple's CEO Tim Cook and China's Minister of Industry and Information Technology, Li Lecheng, discussing Apple's business development in China and cooperation in the electronics sector [1] Group 1: Stock Performance - Hon Teng Precision increased by 6.4% [1] - BYD Electronics rose nearly 6% [1] - Lens Technology gained 3.5% [1] - AAC Technologies saw a 2% increase [1] - FIH Mobile and Sunny Optical also experienced upward movement [1] Group 2: Corporate Developments - Tim Cook emphasized Apple's commitment to increasing investment in China and enhancing cooperation for mutual benefits [1] - Sabih Khan, the new COO, visited China for the first time to engage with the "Apple supply chain" [1] - Apple reported that over 90% of its manufacturing in China now utilizes renewable energy, with more than 100 suppliers contributing to this achievement [1]

| 代码 | 名称 | 最新价 | 涨跌幅 ^ | | --- | --- | --- | --- | | 06088 | 倒蝶糖製 | 5.750 | -10.58% | | 06613 | 蓝思科技 | 26.780 | -8.22% | | 02382 | 舜宇光学科技 | 79.500 | -6.03% | | 01415 | 高伟电子 | 34.380 | -5.81% | | 00856 | 伟仕佳杰 | 9.280 | -5.60% | | 02018 | 瑞声科技 | 40.920 | -5.50% | | 00285 | 比亚迪电子 | 39.480 | -4.68% | | 02283 | 东江集团控股 | 2.470 | -4.63% | | 02038 | 富智康集团 | 16.810 | -4.81% | | 01478 | 丘钛科技 | 15.180 | -4.41% | 港股苹果概念股集体下挫，其中，鸿腾精密跌超10%，蓝思科技跌超8%，舜宇光学跌6%，高伟电子跌 5.8%，瑞声科技、伟仕佳杰跌5.5%，比亚迪电子、富智康集团、丘钛科技跌超4%以上。 消息上，有分析称，港股市场科 ...

Core Viewpoint - Guangdong Zhongsu New Materials Co., Ltd. (Zhongsu Co.) has received approval for its IPO on the ChiNext board, focusing on the research, production, and sales of modified engineering plastics, with applications in various industries including consumer electronics, energy storage, automotive, and home appliances [1][2]. Financial Performance - In 2024, Zhongsu Co. achieved a revenue of 700 million yuan and a net profit of 92.57 million yuan after deducting non-recurring gains and losses [1][2]. - The company's revenue for the years 2022 to 2024 was 493 million yuan, 537 million yuan, and 700 million yuan, with a compound annual growth rate (CAGR) of 19.11% and 37.79% for net profit during the same period [2]. Gross Margin - Zhongsu Co.'s gross margin for its main business was 31.03% in 2024, significantly higher than the industry average of 21.42%, representing a difference of 9.61 percentage points [1][2][3]. - The gross margins for the years 2022 to 2024 were 26%, 31.97%, and 31.03%, respectively, compared to industry averages of 21.15%, 24.31%, and 21.42% [2]. Research and Development - The R&D expense ratios for Zhongsu Co. from 2022 to 2024 were 3.12%, 2.93%, and 3.62%, which were below the industry averages of 4.40%, 4.71%, and 3.92% for the same periods [4]. - As of March 31, 2025, the company had 66 R&D personnel, with 56.06% holding a diploma or lower [4]. Funding and Projects - Zhongsu Co. plans to raise approximately 645.49 million yuan through its IPO to fund projects including the construction of a high-performance engineering materials intelligent production base, expansion of the Jiangxi Zhongsu production base, establishment of a new materials engineering technology research center, and to supplement working capital [1].

消息面上，Counterpoint此前发布报告称，2025年第三季度前八周，中国智能手机市场销量同比下降 2%，这与期内促销活动和国家补贴政策加剧了中高端市场的竞争且消费者更倾向购买中高端产品有 关。该机构预计，2025年第三季度中国智能手机市场将小幅下跌，而全年表现大体持平。 值得注意的是，OpenAI此前与果链龙头企业立讯精密（002475）达成战略合作。里昂表示，考虑到 OpenAI的设备团队核心成员均来自苹果公司，其选择与苹果供应链企业合作亦属合理。预计有关举措 可为现有苹果供应链企业带来新增长动力。 苹果概念股全线下跌，截至发稿，高伟电子(01415)跌5.32%，报36.64港元；富智康集团(02038)跌 5.05%，报17.66港元；比亚迪（002594）电子(00285)跌4.28%，报41.58港元；丘钛科技(01478)跌 3.33%，报15.98港元。 ...

Core Viewpoint - The strategic partnership between Wuhan Haocun Technology Co., Ltd. and Lingxin Qiaoshou (Beijing) Technology Co., Ltd. aims to integrate Haocun's "Motor Neuron Central System" with Lingxin's advanced dexterous hand technology to overcome technical bottlenecks in humanoid robots' fine operations and intelligent interactions, promoting the large-scale application of embodied intelligence in various sectors such as industry, healthcare, and services [1][6][11]. Technical Integration - The collaboration focuses on deep cooperation in humanoid robot motion control and fine operations, creating a complete technical loop from action decision-making to end execution [1][6]. - Haocun's "Motor Neuron Central System" achieves a precision of 0.001 degrees and a data transmission delay of 3 milliseconds, addressing core challenges in humanoid robot motion control [3]. - Lingxin's Linker Hand series dexterous hands have a freedom degree of 25-30 for the industrial version and up to 42 for the research version, surpassing competitors like the UK's Shadow Hand and Tesla's Optimus Prime [3]. Industry Empowerment - The partnership aims to accelerate the commercialization of humanoid robot technology across diverse scenarios, particularly in industrial manufacturing, healthcare, and domestic services [6]. - Haocun's motion control system combined with Lingxin's dexterous hands will significantly enhance robots' flexibility and precision on assembly lines, with existing collaborations with major industrial players like Foxconn and BYD [6]. - The integration of technologies from both companies represents a crucial pathway for humanoid robots to achieve fine operations, with potential applications in rehabilitation training and high-sensitivity commercial tasks [6][11]. Synergistic Effects - The complementary technologies of both companies create significant synergies, forming a more complete "perception-decision-execution" loop [8]. - Haocun's system acts as the "brain" of the robot, while Lingxin's dexterous hands serve as the "hands," enhancing the robot's capabilities for fine manipulation [8]. - The collaboration aligns with Haocun's strategy to seek partnerships across the industry chain to meet the growing market demand for robotic training [8]. Summary - The partnership between Haocun Technology and Lingxin Qiaoshou reflects a trend in the Chinese robotics industry towards ecological collaboration, aiming to accelerate core technological breakthroughs and industrial applications [11].

Group 1 - Apple-related stocks collectively declined, with Lens Technology and Hong Teng Precision falling over 5% [1] - BYD Electronics, Qiu Tai Technology, and FIH Mobile dropped more than 3% [1] - Shunyu Optical Technology and Highwei Electronics decreased by over 2% [1]

致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 公司名稱: 富智康集團有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02038 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | USD | | 0.4 USD | | 800,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | | | 本月底結存 | | | 2,000,000,000 | USD | | 0.4 USD | | 800,000,000 | 本月底法定/註冊股本總額： USD 800,000, ...